Pharmacological characterization of potent and selective NaV1.7 inhibitors engineered from Chilobrachys jingzhao tarantula venom peptide JzTx-V.
PLoS One
; 13(5): e0196791, 2018.
Article
in En
| MEDLINE
| ID: mdl-29723257
Full text:
1
Database:
MEDLINE
Main subject:
Peptides
/
Spider Venoms
/
Sodium Channel Blockers
/
NAV1.7 Voltage-Gated Sodium Channel
/
Analgesics
Type of study:
Prognostic_studies
Language:
En
Journal:
PLoS One
Year:
2018
Type:
Article
Affiliation country:
United States